Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0.0741687979539642 0.0741687979539642 0.0741687979539642
Stock impact report

Stemline Therapeutics Announces Positive Data Presentations on SL-701 and SL-801 at ASCO

STEMLINE THERAPEUTICS (STML) 
Last stemline therapeutics earnings: 3/13 04:45 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.stemline.com/investor-relations
Company Research Source: GlobeNewswire
NEW YORK, June 05, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, announced today that positive data from the SL-701 and SL-801 clinical trials were presented at the 2018 American Society of Clinical Oncology (ASCO) annual meeting in Chicago, IL. The presentations are available on Stemline’s website (www.stemline.com) under the Scientific Presentations tab. SL-701 – Clinical Highlights The Phase 2 trial of SL-701 in previously treated GBM patients met its primary endpoint of 12-month overall survival (OS-12)Long-term survivors: 50% OS-12 with SL-701 + bevacizumab Major responses, including complete responses (CRs), in second-line GBMWell-tolerated, with very manageable side effect profile Long-term survivors were comprised largely of patients with target-specific CD8+ T-cell responses Median OS of target-specific CD8+ T cell responders not reached Given the major unmet medical n Show less Read more
Impact Snapshot
Event Time:
STML
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for STML alerts
Opt-in for
STML alerts

from News Quantified
Opt-in for
STML alerts

from News Quantified